
    
      The PLATIN trial is designed as a prospective, non-randomized, five-arm trial. Arm 1:
      Definitive radiotherapy of the pelvic lymphatic drainage with integrated boost to the
      prostate.

      Arm 2: As arm 1, with additional boost to macroscopic lymph node metastases. Arm 3:
      Postoperative radiotherapy of the pelvic lymphatic drainage with integrated boost to the
      prostate bed.

      Arm 4: As arm 3, additional boost to macroscopic lymph node metastases. Arm 5: Patients with
      previous radiotherapy to the prostate bed. Radiotherapy of the pelvic lymphatic drainage
      above the previous treatment fields with integrated boost to macroscopic lymph node
      metastases.
    
  